Related Experiment Video

Updated: May 7, 2026

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 22, 2010

35.4K

RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1

Jeehye Park1,2,3, Ismael Al-Ramahi1,2, Qiumin Tan1,2,3

  • 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.

Nature
|May 31, 2013
PubMed

Insights

Researchers identified a genetic network targeting the RAS-MAPK-MSK1 pathway to reduce toxic protein levels in spinocerebellar ataxia type 1 (SCA1). This discovery offers new therapeutic strategies for SCA1 and similar neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Neurodegenerative diseases like Alzheimer's, Parkinson's, and polyglutamine diseases share a common pathology: abnormal accumulation of disease-causing proteins.
  • This accumulation results from either impaired protein degradation or overexpression of wild-type proteins.
  • Identifying therapeutic targets that modulate these protein levels is crucial for treating these intractable conditions.

Purpose of the Study:

  • To develop and apply a screening strategy for identifying genetic networks that influence disease-driving protein levels.
  • To uncover novel therapeutic entry points for neurodegenerative disorders, using spinocerebellar ataxia type 1 (SCA1) as a model.
  • To validate the identified targets in preclinical models and assess their therapeutic potential.

Main Methods:

  • Integrated parallel cell-based and Drosophila genetic screens to identify genetic networks affecting ataxin 1 (ATXN1) levels.
  • Utilized a disease model for spinocerebellar ataxia type 1 (SCA1), caused by polyglutamine tract expansion in ATXN1.
  • Tested the effect of pharmacological inhibitors of identified pathway components in Drosophila and mice models.

Main Results:

  • The genetic screens revealed that downregulation of components within the RAS-MAPK-MSK1 pathway significantly decreases ATXN1 protein levels.
  • Reduced ATXN1 levels led to the suppression of neurodegeneration in both Drosophila and mouse models of SCA1.
  • Pharmacological inhibition of key pathway components demonstrated a similar effect, reducing ATXN1 levels.

Conclusions:

  • The RAS-MAPK-MSK1 pathway represents a novel therapeutic target for spinocerebellar ataxia type 1 (SCA1).
  • Pharmacological targeting of this pathway offers a promising strategy for mitigating SCA1.
  • This approach provides a proof-of-principle for developing treatments for other intractable neurodegenerative diseases characterized by protein aggregation.

More Related Videos

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.1K
Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration08:41

Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration

Published on: December 27, 2024

1.5K

Related Concept Videos

Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.3K